SCHEMBL12609108

SCHEMBL12609108

NCCSSCCNc1ncnc2ccsc12

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 0.52
▸ PDE4B Q07343 1/20 0.52
▸ PDE4C Q08493 1/20 0.52
▸ PDE4D Q08499 1/20 0.52
▸ PDE3B Q13370 1/20 0.52
▸ PDE3A Q14432 1/20 0.52
▸ AURKB Q96GD4 13/20 0.45
▸ AURKA O14965 7/20 0.44
▸ FADS1 O60427 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ PIP4K2C Q8TBX8 1/20 0.40
▸ IRAK4 Q9NWZ3 1/20 0.40
▸ AXL P30530 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12609107 0.77 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL13653497 0.77 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL12651261 0.76 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL5368863 0.73 S1PR2 (0.56) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL236692 0.73 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL30715844 0.73 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL2876445 0.73 AURKB (0.58) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL13689922 0.71 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL2878014 0.71 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL18878177 0.71 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2257637-B1 METHODS OF CHEMOTYPE EVOLUTION SUNESIS PHARMACEUTICALS INC (US) 2015-09-23 — — EP disclosed
US-20110118126-A1 METHODS OF CHEMOTYPE EVOLUTION SUNESIS PHARMACEUTICALS, INC. 2011-05-19 — — US disclosed
US-20110118126-A1 METHODS OF CHEMOTYPE EVOLUTION SUNESIS PHARMACEUTICALS, INC. 2011-05-19 — — US disclosed
WO-2009120795-A1 METHODS OF CHEMOTYPE EVOLUTION SUNESIS PHARMACEUTICALS, INC. (US) 2009-10-01 — — WO disclosed
Send feedback